Loading...
The most effective reversible contraceptives are the etonogestrel subdermal implant and the 52-mg levonorgestrel intrauterine device (LNG-IUD). The FDA has approved the etonogestrel implant (Nexplanon) and the 52-mg LNG-IUD (Mirena) for 3 and 5 years of use, respectively. To investigate contraceptive effectiveness beyond these timeframes, researchers conducted a manufacturer-supported observational study involving 291 women who had already used the implant for 3 years and 496 who had used the LNG-IUD for 5 years.
During the 2-year study, no pregnancies occurred in the implant group. The calculated failure rate was 0 per 100 women-years (one-sided 97.5% confidence interval, 0–1.48) in year 4 of use and 0 per 100 women-years (one-sided 97.5% CI, 0–2.65) in year 5 of use. Two pregnancies occurred in the LNG-IUD group. The calculated failure rate in year 6 of use was 0.25 per 100 women-years (95% CI, 0.04–1.42) and in year 7 of use was 0.43 per 100 women-years (95% CI, 0.08–2.39).
McNicholas C et al. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device — two years beyond FDA-approved duration. Am J Obstet Gynecol 2017 Jan 29; [e-pub]. (http://dx.doi.org/10.1016/j.ajog.2017.01.036)
Comment
This large study adds to a growing body of evidence demonstrating the effectiveness of the etonogestrel implant for 5 years and the 52-mg LNG-IUD for up to 7 years. Women of any age can use the implant for up to 5 years (NEJM JW Womens Health Nov 2016 and Hum Reprod 2016; 31:2491). Among the 3 available doses of the LNG-IUD, extended use should only be considered for the 52-mg dose. Younger LNG-IUD users have slightly higher risk for pregnancy; accordingly, to balance risk and benefit for my patients who would like to consider extended use of the 52-mg LNG-IUD, I offer those who are younger than 35 up to 6 years of use, and those who are 35 or older up to 7 years of use. For women who prefer to exchange their 52-mg LNG-IUD with a new device at 5 years, I accede to their preference.